Drug – bio-affecting and body treating compositions – Designated organic nonactive ingredient containing other... – Solid synthetic organic polymer
Patent
1992-06-30
1994-02-15
Kight, III, John
Drug, bio-affecting and body treating compositions
Designated organic nonactive ingredient containing other...
Solid synthetic organic polymer
424426, 523113, 523115, 528271, 528354, 6048911, 514 30, 514 40, A61M 3100, C08G 6302
Patent
active
052867633
ABSTRACT:
Bioerodible polymers which degrade completely into nontoxic residues over a clinically useful period of time, including polyanhydrides, polyorthoesters, polyglycolic acid, polylactic acid, and copolymers thereof, are used for the delivery of bioactive agents, including antibiotics, chemotherapeutic agents, inhibitors of angiogenesis, and simulators of bone growth, directly into bone.
REFERENCES:
patent: 3887699 (1975-06-01), Yolles
patent: 3991766 (1976-11-01), Schmitt et al.
patent: 4419340 (1983-12-01), Yolles
patent: 4563489 (1986-01-01), Wrist et al.
patent: 4612009 (1986-09-01), Drobnik et al.
patent: 4675189 (1987-06-01), Kent et al.
patent: 4797282 (1989-01-01), Wahlig et al.
patent: 4806621 (1989-02-01), Kohn et al.
patent: 4832686 (1989-05-01), Anderson
patent: 4906474 (1990-03-01), Langer et al.
patent: 5122367 (1992-06-01), Ron et al.
Domb Abraham J.
Gerhart Tobin N.
Hayes Wilson C.
Langer Robert S.
Laurencin Cato T.
Dodson Shelley A.
Kight III John
Massachusetts Institute of Technology
LandOfFree
Bioerodible polymers for drug delivery in bone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bioerodible polymers for drug delivery in bone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bioerodible polymers for drug delivery in bone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1207403